Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Assets (2019 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Return on Assets for 8 consecutive years, with 0.33% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets fell 30.0% year-over-year to 0.33%; the TTM value through Mar 2026 reached 0.33%, down 30.0%, while the annual FY2025 figure was 0.27%, 28.0% down from the prior year.
  • Return on Assets hit 0.33% in Q1 2026 for Bicycle Therapeutics, down from 0.3% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.01% in Q4 2024 and bottomed at 0.33% in Q1 2026.
  • Average Return on Assets over 5 years is 0.21%, with a median of 0.24% recorded in 2022.
  • Year-over-year, Return on Assets soared 31bps in 2024 and then crashed -32bps in 2025.
  • Bicycle Therapeutics' Return on Assets stood at 0.28% in 2022, then fell by -8bps to 0.3% in 2023, then soared by 104bps to 0.01% in 2024, then tumbled by -2899bps to 0.3% in 2025, then decreased by -8bps to 0.33% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.33%, 0.3%, and 0.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.